IP Library Granted Patent US 12,667,837
Granted Patent B2
US 12,667,837 · App. 18/146,188 · Granted Jun 30, 2026

Methods of measuring hematocrit in fluidic channels including conductivity sensor

Inventor: James Russell Webster (Minnetonka, MN)
Assignee: Zomedica Biotechnologies LLC
B01L3/502G01F1/584G01N27/08G01N33/49B01L2200/0605B01L2200/14B01L2200/16B01L2300/0645B01L2300/0663
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,667,837
App. No.
18/146,188
Filed
Dec 23, 2022
Granted
Jun 30, 2026
Kind
B2
Art Unit
1758
USPC
436/70
Abstract

A device and a method of using the device for determining hematocrit in a whole blood sample. The device includes a first portion having an introducer, at least one fluid channel, a fluid actuator, and an analysis sensor and conductivity sensor disposed within the fluid channel. The second portion includes at least one well containing at least one material. The first portion and second portion are movable with respect to each other. The introducer is configured to transfer at least a portion of the material from the well in portion two into the fluid channel of portion one. The method includes measuring the resistance over substantially the entire portion of a whole blood sample and calculating an average hematocrit level of the whole blood sample based on the measured resistance.

Claims (34)

1 . A system for determining hematocrit level in a blood sample, the system comprising:

a first portion, the first portion comprising:

at least one fluid channel, wherein the fluid channel is a microfluidic channel;

a fluid actuator;

an analyte sensor disposed within the fluid channel;

a conductivity sensor comprising at least two electrodes, the conductivity sensor disposed within the fluid channel upstream of the analyte sensor; and

an introducer; and

a second portion, the second portion comprising at least one well configured to hold at least one material;

wherein at least one of the first and second portions is moveable with respect to the other; and

wherein the introducer is configured to obtain at least a portion of the material from the at least one well and deliver it to the fluid channel, and wherein the fluid actuator is configured to move at least a portion of the material in the fluid channel to allow the hematocrit level of the blood sample to be determined.

2 . The system of claim 1 , wherein the conductivity sensor is configured to measure a resistance within the fluid channel.

3 . The system of claim 2 , wherein the system is configured to determine the hematocrit level of the blood sample using the measured resistance.

4 . The system of claim 1 , wherein the blood sample is a whole blood sample, and the determined hematocrit level is an average hematocrit level of substantially the entire portion of the whole blood sample.

5 . The system of claim 4 , wherein substantially the entire portion of the whole blood sample is at least 75% of the whole blood sample.

6 . The system of claim 4 , wherein substantially the entire portion of the whole blood sample is at least 85% of the whole blood sample.

7 . The system of claim 4 , wherein substantially the entire portion of the whole blood sample is at least 95% of the whole blood sample.

8 . The system of claim 1 , wherein the conductivity sensor is located adjacent to the introducer upstream of the analyte sensor.

9 . The system of claim 1 , wherein the at least two electrodes are located no more than 3 mm away from each other.

10 . The system of claim 1 , wherein the at least two electrodes are located no more than 1 mm away from each other.

11 . The system of claim 1 , wherein the analyte sensor is a resonator sensor.

12 . The system of claim 1 , wherein the at least two electrodes comprise a substantially chemically inert material.

13 . A method of determining hematocrit level in a whole blood sample utilizing a fluidic device, the method comprising:

moving the whole blood sample in a fluidic channel of the fluidic device, wherein the fluidic channel is a microfluidic channel;

detecting a resistance at a conductivity sensor in the fluidic channel, wherein the conductivity sensor comprises at least two electrodes, and wherein the conductivity sensor is located upstream of an analyte sensor in the fluidic channel;

measuring, at the conductivity sensor, the resistance over substantially the entire portion of the whole blood sample; and

calculating the hematocrit level of the whole blood sample based on the measured resistance at the conductivity sensor.

14 . The method according to claim 13 , wherein substantially the entire portion of the whole blood sample is at least 75% of the whole blood sample.

15 . The method according to claim 13 , wherein substantially the entire portion of the whole blood sample is at least 85% of the whole blood sample.

16 . The method according to claim 13 , wherein substantially the entire portion of the whole blood sample is at least 95% of the whole blood sample.

17 . The method according to claim 13 , wherein the hematocrit level of the whole blood sample is calculated by integrating the area under a curve of time versus the measured resistance.

18 . The method according to claim 13 , wherein the calculated hematocrit level is an average hematocrit level of substantially the entire portion of the whole blood sample.

19 . The method according to claim 13 , wherein the at least two electrodes are located no more than 10 mm away from each other.

20 . The method according to claim 13 , wherein the at least two electrodes are located no more than 3 mm away from each other.

21 . The method according to claim 13 , wherein the at least two electrodes are located no more than 1 mm away from each other.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 16, 2023
From: QORVO US, INC.
To: QORVO BIOTECHNOLOGIES, LLC
Reel/Frame 065891/0500 →
CHANGE OF NAME Recorded Dec 16, 2023
From: QORVO BIOTECHNOLOGIES, LLC
To: ZOMEDICA BIOTECHNOLOGIES LLC
Reel/Frame 066047/0683 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 4, 2023
From: QORVO US, INC.
To: QORVO BIOTECHNOLOGIES, LLC
Reel/Frame 065124/0829 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 3, 2023
From: WEBSTER, JAMES RUSSELL
To: QORVO US, INC.
Reel/Frame 062260/0105 →
Continuity (5)
Continuation 16120225 · Sep 1, 2018
Provisional Application 62694621 · Jul 6, 2018
Provisional Application 62694599 · Jul 6, 2018
Provisional Application 62694594 · Jul 6, 2018
Related Publication 20230133768A1 · May 4, 2023
References Cited (54)
US 4547735A · Kiesewetter et al. · 1985 [cited by applicant]
US 6058934A · Sullivan · 2000 [cited by applicant]
US 11344878B2 · Webster · 2022 [cited by applicant]
US 11541385B2 · Webster · 2023 [cited by applicant]
US 11612887B2 · Webster · 2023 [cited by applicant]
US 20010049148A1 · Wolk et al. · 2001 [cited by applicant]
US 20020015667A1 · Chow · 2002 [cited by applicant]
US 20030203504A1 · Hefti · 2003 [cited by applicant]
US 20080297169A1 · Greenquist et al. · 2008 [cited by applicant]
US 20090084678A1 · Joshi et al. · 2009 [cited by applicant]
US 20110201099A1 · Anderson et al. · 2011 [cited by applicant]
US 20120258472A1 · Roy et al. · 2012 [cited by applicant]
US 20120329144A1 · Kwak et al. · 2012 [cited by applicant]
US 20140273265A1 · Feingold et al. · 2014 [cited by applicant]
US 20160091506A1 · Webster · 2016 [cited by applicant]
US 20160091511A1 · Di Tullio et al. · 2016 [cited by applicant]
US 20160116444A1 · Webster et al. · 2016 [cited by applicant]
US 20200011825A1 · Webster · 2020 [cited by applicant]
US 20200011849A1 · Webster et al. · 2020 [cited by applicant]
US 20220241769A1 · Webster · 2022 [cited by applicant]
US 20230133768A1 · Webster · 2023 [cited by applicant]
US 20230234045A1 · Webster · 2023 [cited by applicant]
CN 104427929A · 2015 [cited by applicant]
CN 105452858A · 2016 [cited by applicant]
GB 2501128A · 2013 [cited by applicant]
JP 2005283163A · 2005 [cited by applicant]
JP 2006167706A · 2006 [cited by applicant]
JP 2006329899A · 2006 [cited by applicant]
JP 2009276275A · 2009 [cited by applicant]
WO WO2013153406A1 · 2013 [cited by applicant]
WO WO2014190295A2 · 2014 [cited by applicant]
WO WO2016049557A1 · 2016 [cited by applicant]
WO 2017195038A1 · 2017 [cited by applicant]
WO 2020009896A1 · 2020 [cited by applicant]
WO 2020009897A1 · 2020 [cited by applicant]
Office Action dated Mar. 31, 2023 from Chinese Application No. 201980045635.4, original and English translation, 10 pages. [cited by applicant]
Office Action dated Mar. 31, 2023 from Chinese Application No. 201980045868.4, original and English translation, 15 pages. [cited by applicant]
Office Action dated Apr. 11, 2023 from Japanese Application No. 2021-500195, original and English translation, 8 pages. [cited by applicant]
International Search Report and Written Opinion for PCT Application No. PCT/US2019/039465 dated Sep. 5, 2019, 10 pages. [cited by applicant]
International Preliminary Report on Patentability for PCT Application No. PCT/US2019/039465 dated Jan. 12, 2021, 8 pages. [cited by applicant]
International Search Report and Written Opinion for PCT Application No. PCT/US2019/039470 dated Sep. 17, 2019, 9 pages. [cited by applicant]
International Preliminary Report on Patentability for PCT Application No. PCT/US2019/039470 dated Jan. 12, 2021, 7 pages. [cited by applicant]
Extended European Search Report mailed Feb. 28, 2022 in related application EP 19831195.3, 7 pages. [cited by applicant]
Extended European Search Report mailed Feb. 28, 2022 in related application EP 19831197.9, 7 pages. [cited by applicant]
Burns et al., “An Integrated Nanoliter DNA Analysis Device”, Science, vol. 282, Oct. 16, 1998, pp. 484-487. [cited by applicant]
Jung et al. “Determination of hematocrit using on-line conductance cell,” International Journal of Heat and Mass Transfer 55 (2012), 1836-1843. [cited by applicant]
Kim et al. “Improvement of the accuracy of continuous hematocrit measurement under various blood flow conditions” Appl. Phys. Lett. 104, 153508 (2014). [cited by applicant]
Kim et al. “Improvement of electrical blood hematocrit measurements under various plasma conditions using a novel hematocrit estimation parameter” Biosensors and Bioelectronics 35 (2012) 416-420. [cited by applicant]
Rothe et al. “Continuous measurement of conductivity of biological fluids” Journal of Applied Physiology vol. 23, No. 6, Dec. 1967. [cited by applicant]
Sandberg et al., “Relation Between Blood Resistivity and Hematocrit in Fresh Human Fetal Blood”, Pediatr. Res. 15, 1981, pp. 964-966. [cited by applicant]
Teodorczyk et al. “Hematocrit Compensation in Electrochemical Blood Glucose Monitoring Systems”, J. Diabetes Sci. Technol. vol. 6, Issue 3, May 2012. [cited by applicant]
Trebbels et al. “Capacitive on-line hematocrit sensor design based on Impedance Spectroscopy for use in hemodialysis machines” 31st Annual International Conference of the IEEE EMBS Minneapolis, Minnesota, USA, Sep. 2-6,… [cited by applicant]
Zhbanov et al. “Electrochemical impedance spectroscopy of blood for sensitive detection of blood hematocrit, sedimentation and dielectric properties” Anal. Methods, 2017, 9, 3302-3313. [cited by applicant]
Office Action mailed May 16, 2023 in Japanese application No. 2021-500212, with English translation, 8 pages. [cited by applicant]